09 March 2001
Liver Transplan twithou ta Venovenous Bypass
Krzysztof Witkowski, Jerzy PiecuchAnn Transplant 2001; 6(1): 16-17 :: ID: 497566
Abstract
The problem whether to use or not to use a venovenous bypass in liver transplantation isthe point of a discussion and the subject of controversies among anaesthetists and transplant surgeons. Some emphasize the advantages of using a venovenous bypass such as stabilization of the blood flow resulting from maintaining appropriate venous inflow to the heart, maintenance of perfusion pressure in the kidneys, decrease in bleeding and greater comfort for the operating surgeon. The opponents observe possible complications such as air embolism, thrombi of cannulated vessels, a hypothermia hazard, prolongation of the operation. The operation without application of extrasystemic venous circulation could be a good method especially for the patients with no circulatory failure before the operation but for experienced anaesthetists and transplant surgeons only.
Keywords: Liver Transplantation, venovenous bypass
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






